In the News
Pacific Biosciences announced that Suqian Lakeside Pangu Gene Company (SLPC) established a new 1,500 square meter genomics facility in Tianjin, China dedicated to using PacBio Single Molecule, Real Time (SMRT®) Sequencing as the major sequencing platform for its translational medicine research projects.
Pacific Biosciences, provider of the PacBio RS II DNA Sequencing System, announced the release of new chemistry and software designed to enhance read length and accuracy for the study of human and other complex genomes.
Production of Cornell’s newest apple varieties is ramping up with SnapDragon coming to market in limited quantities this November and RubyFrost becoming available through several retailers in January 2015.
Hurel, a provider of in vitro liver models that bring improved translational utility to pre-clinical drug development, and ACEA Biosciences, provider of impedance-based, label-free, real-time cell analysis instrumentation, announced that they will begin to offer their respective technologies combined together in a single, integrated cell-based assay platform with a launch planned for the first quarter of 2015.
Armory Square Ventures, a new venture fund, has closed its first investment as part of a $2.2 million round of financing for Agronomic Technology Corp.
Researchers at Weill Cornell Medical College have developed technologies that allow investigators to watch HIV proteins on the virus’ surface, which may contribute to how it infects human immune cells.
Human Longevity, Inc. has added Pacific Bioscience’s Single Molecule, Real-Time (SMRT®) Sequencing technology to their repertoire of DNA sequencing technologies to compile a comprehensive human genotype, microbiome, and phenotype database.
Life Extension announced the launch of NAD+ Cell Regenerator™, a nutritional supplement that boosts vitality and supports healthy aging, featuring the ingredient NIAGEN™ from ChromaDex, a natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. NIAGEN™ is the commercially available brand of Nicotinamide Riboside (NR), developed at Cornell.
Aromella is a limited release varietal white wine that is semi-dry white and marked by peach and tropical fruit aromas, similar to the trendy Italian wine, Moscato.
Hurel, provider of in vitro liver models and microfluidic assay platforms that improve the predictive reliability of pre-clinical drug development, announced that Johnston Assoicates, Inc. has become a participating investor in the company’s Series A-3 Preferred Stock financing.
Pacific Biosciences, provider of the PacBio RS II DNA Sequencing System, announced that Macrogen, providers of genome sequencing services, has selected the PacBio Single Molecule, Real-Time (SMRT) Sequencing platform to create high-quality de novo human genome references for the Asian population. The current human genome reference was predominantly derived from a Caucasian individual and its utility is limited for researchers investigating certain diseases that differ genetically between ethnicities.
A genetically engineered tobacco plant, developed with two genes from blue-green algae, holds promise for improving yields of many food crops.
Metabolon, a life sciences company focused on the study of small molecules and an integral technology for understanding the function of biological systems, has partnered with Metdia Biotech, S.L. to commercialize its Quantose IR™ and Quantose IGT™ prediabetes tests in Spain, Portugal, France, Italy, the United Kingdom, Germany, Switzerland, Sweden, Norway, Denmark, Finland, the Netherlands, Belgium, and Austria.
Pacific Biosciences, creators of the PacBio RS II DNA Sequencing System, announced the publication of several papers highlighting the advantages of Single Molecule, Real-Time (SMRT) Sequencing over short-read sequencing technologies for infectious disease applications.
BinOptics, developers of semiconductor lasers for the Telecom and Datacom industries, announced the availability of 25G lasers at four wavelengths, allowing 100G solutions for Data Centers that will provide an increase in data transfer with lower power consumption per bit of transferred data.
For archived news items, click here.